GTechnology · Information Technology ServicesThe 12 Wall Street analysts covering Genpact Ltd. hold a median 12-month price target of $43 — +8.5% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 92 of 100 as at 31 Oct 2026 — among the strongest tenth. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores Genpact Ltd. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Volatility (99): The share price has been relatively steady.
Momentum (39): The shares have been drifting down relative to others.
Size (19): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on G, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +8.5% from it.
Of the 20 most recent actions, 5 moved their price target up and 3 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 22 Oct 2026 | Susquehanna | Maintains | Neutral | $37 → $40 |
| 7 Aug 2026 | Citigroup | Maintains | Neutral | — |
| 7 Aug 2026 | Citigroup | Maintains | Neutral | $32 → $36 |
| 7 Aug 2026 | JP Morgan | Maintains | Neutral | $40 → $45 |
| 7 Aug 2026 | JP Morgan | Maintains | Neutral | — |
| 7 Aug 2026 | Needham | Maintains | Buy | — |
| 7 Aug 2026 | Needham | Maintains | Buy | $50 → $45 |
| 7 Aug 2026 | Susquehanna | Maintains | Neutral | $33 → $37 |
| 7 Aug 2026 | Susquehanna | Maintains | Neutral | — |
| 7 Aug 2026 | TD Cowen | Maintains | Buy | — |
| 7 Aug 2026 | TD Cowen | Maintains | Buy | $42 → $43 |
| 9 July 2026 | TD Cowen | Maintains | Buy | — |
| 9 July 2026 | TD Cowen | Maintains | Buy | $47 → $42 |
| 7 July 2026 | Baird | Maintains | Neutral | — |
| 7 July 2026 | Baird | Maintains | Neutral | $45 → $38 |
| 11 May 2026 | Baird | Maintains | Neutral | — |
| 11 May 2026 | Citigroup | Maintains | Neutral | — |
| 11 May 2026 | Mizuho | Maintains | Neutral | — |
| 8 May 2026 | Needham | Reiterates | Buy | — |
| 5 May 2026 | Susquehanna | Maintains | Neutral | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
G appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 30 Oct 2026, Genpact Ltd. returned +5.6% against +12.4% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 53% of US stocks
Cheaper than 63% of US stocks
Cheaper than 35% of US stocks
Cheaper than 43% of US stocks
Higher than 45% of US stocks
Higher than 48% of US stocks
Higher than 44% of US stocks
Higher than 73% of US stocks
Higher than 72% of US stocks
Higher than 83% of US stocks
Higher than 91% of US stocks
Higher than 78% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Genpact Ltd. has a market value of $6.6B and an enterprise value of $7.4B.
Revenue in the twelve months to 30 June 2026: $5.3B. The latest quarter grew 7.1% year on year.
Net income over the same four quarters: $582.7M, a 11.1% net margin.
Diluted earnings per share, trailing twelve months: $3.37.
Free cash flow in the twelve months to 30 June 2026: $548.7M.
Genpact Ltd. spent $310.1M on share buybacks and $121.7M on dividends in the twelve months to 30 June 2026.
Trailing P/E: 11.8×; forward P/E: 8.8× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 1.90%, paying out 21% of earnings.
Genpact Ltd. employs 141,000 people — $37K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Genpact Ltd. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Zacks Investment Research says Genpact lacks the two key ingredients it associates with a likely earnings beat in the upcoming report, and outlines key expectations.
Why it matters — G watchers may note the report's cautious assessment of the potential for an earnings beat ahead of Genpact's upcoming results.
Genpact was named a Leader overall in NelsonHall’s 2026 NEAT evaluation for Finance and Accounting Transformation. It also received Leader recognition across P2P, R2R, O2C, Agentic AI Capabilities, and CFO Advisory Capabilities.
Why it matters — The recognition highlights Genpact’s standing across finance transformation services and capabilities relevant to CFOs.
AT&T and Smart Meter are expanding their collaboration to provide connectivity for remote patient monitoring devices in more locations across the United States. The effort supports healthcare providers using connected devices for patients managing chronic conditions outside traditional care settings.
Why it matters — The item describes an expansion in connected healthcare, but the excerpt does not mention Genpact or a direct effect on its business.
Zacks Investment Research says Genpact has a strong history of earnings surprises and currently has two key factors it views as supporting a likely beat in the next quarterly report.
Why it matters — The item highlights factors that may shape expectations for Genpact’s upcoming earnings report.
Genpact received the Growth Honor of the Year in Everest Group’s 2026 Elevate Honors. The award recognizes the strongest year-over-year organic, constant-currency revenue growth among publicly listed global service providers with annual revenue above $5 billion over the 16 months ending June 2026.
Why it matters — The honor highlights Genpact’s organic revenue growth as it scales Agentic Operations for global enterprises.
The 12 Wall Street analysts covering Genpact Ltd. have a median 12-month price target of $43, with estimates ranging from $36 to $58. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 12 analysts covering Genpact Ltd., 5 rate it a Buy, 7 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Genpact Ltd. 92 out of 100 across roughly 4,600 US stocks as at 31 Oct 2026. None of this is personal advice — it does not consider your circumstances.
As at 31 Oct 2026, Genpact Ltd. ranks 92 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (99 of 100).
No one can know that. What the data says: the median 12-month target from 12 analysts implies +8.5% from the last close, and Ticker Nerd's factor model ranks Genpact Ltd. 92 out of 100 as at 31 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Genpact Ltd. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for G are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $36 to $58 over the next 12 months.
Genpact Ltd. returned +5.6% over the 12 months to 30 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
Genpact Limited is a global professional services and technology company that helps enterprises transform and manage complex operations. Genpact Limited provides digital transformation, business process management, data and analytics, technology consulting, and artificial intelligence services to clients across industries including financial services, consumer and healthcare, and high tech and manufacturing.
The most recent item we track (Zacks Investment Research, 29 Oct 2026): "Genpact (G) Earnings Expected to Grow: Should You Buy?". Zacks Investment Research says Genpact lacks the two key ingredients it associates with a likely earnings beat in the upcoming report, and outlines key expectations.
Genpact Limited is a global professional services and technology company that helps enterprises transform and manage complex operations. Genpact Limited provides digital transformation, business process management, data and analytics, technology consulting, and artificial intelligence services to clients across industries including financial services, consumer and healthcare, and high tech and manufacturing. Its offerings cover functions such as finance and accounting, procurement, supply chain, human resources, sales, and commercial operations, supporting organizations that rely on large-scale, data-driven workflows. The company serves businesses across India, the rest of Asia, North and Latin America, and Europe, positioning itself as an operations partner for multinational enterprises seeking process efficiency and technology-enabled execution. Founded in 1997 and headquartered in Hamilton, Bermuda, Genpact Limited remains focused on combining domain expertise with automation, analytics, and AI to support mission-critical business processes.
CEO Mr. Balkrishan Kalra · 141,000 employees · Bermuda · https://www.genpact.com
